 Vitaly Kheyfets
Concepts (195)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hypertension, Pulmonary | 16 | 2025 | 1957 | 2.550 |
Why?
| | Ventricular Dysfunction, Right | 9 | 2025 | 248 | 2.470 |
Why?
| | Pulmonary Artery | 19 | 2024 | 1129 | 2.400 |
Why?
| | Ventricular Function, Right | 14 | 2025 | 297 | 2.110 |
Why?
| | Heart Ventricles | 12 | 2025 | 756 | 1.810 |
Why?
| | Vascular Resistance | 6 | 2025 | 370 | 1.490 |
Why?
| | Computer Simulation | 10 | 2024 | 1003 | 1.350 |
Why?
| | Pulmonary Circulation | 7 | 2024 | 430 | 1.200 |
Why?
| | Magnetic Resonance Imaging, Cine | 9 | 2021 | 214 | 1.160 |
Why?
| | Ventricular Remodeling | 5 | 2025 | 278 | 1.150 |
Why?
| | Models, Cardiovascular | 7 | 2025 | 196 | 1.030 |
Why?
| | Microvessels | 2 | 2025 | 97 | 0.880 |
Why?
| | Coronary Circulation | 1 | 2025 | 134 | 0.870 |
Why?
| | Vascular Remodeling | 3 | 2025 | 209 | 0.870 |
Why?
| | Microcirculation | 1 | 2025 | 142 | 0.860 |
Why?
| | Hemodynamics | 8 | 2025 | 1118 | 0.810 |
Why?
| | Coronary Vessels | 1 | 2025 | 246 | 0.790 |
Why?
| | Hydrodynamics | 4 | 2025 | 50 | 0.730 |
Why?
| | Regional Blood Flow | 5 | 2021 | 514 | 0.690 |
Why?
| | Pulmonary Embolism | 1 | 2023 | 241 | 0.650 |
Why?
| | Stress, Mechanical | 5 | 2025 | 494 | 0.640 |
Why?
| | Ventilators, Mechanical | 1 | 2020 | 71 | 0.620 |
Why?
| | Positive-Pressure Respiration | 1 | 2020 | 115 | 0.590 |
Why?
| | Fibrosis | 3 | 2021 | 561 | 0.590 |
Why?
| | Magnetic Resonance Angiography | 3 | 2017 | 251 | 0.550 |
Why?
| | Patient-Specific Modeling | 2 | 2017 | 45 | 0.520 |
Why?
| | Algorithms | 5 | 2020 | 1850 | 0.490 |
Why?
| | Pneumonia, Viral | 1 | 2020 | 391 | 0.440 |
Why?
| | Coronavirus Infections | 1 | 2020 | 384 | 0.440 |
Why?
| | Bandages | 1 | 2014 | 41 | 0.410 |
Why?
| | Arterial Pressure | 4 | 2020 | 134 | 0.400 |
Why?
| | Blood Flow Velocity | 5 | 2019 | 421 | 0.400 |
Why?
| | Patients | 1 | 2015 | 183 | 0.390 |
Why?
| | Gravitation | 1 | 2013 | 22 | 0.390 |
Why?
| | Cellulose | 1 | 2013 | 58 | 0.380 |
Why?
| | Materials Testing | 1 | 2014 | 345 | 0.370 |
Why?
| | Ventricular Pressure | 2 | 2024 | 52 | 0.360 |
Why?
| | Drug Carriers | 1 | 2013 | 136 | 0.360 |
Why?
| | Stroke Volume | 7 | 2022 | 655 | 0.350 |
Why?
| | Wound Healing | 1 | 2014 | 355 | 0.340 |
Why?
| | Disease Models, Animal | 6 | 2025 | 4569 | 0.340 |
Why?
| | Hypertension | 1 | 2020 | 1276 | 0.340 |
Why?
| | MicroRNAs | 1 | 2017 | 686 | 0.330 |
Why?
| | Imaging, Three-Dimensional | 2 | 2025 | 583 | 0.330 |
Why?
| | Gene Expression Regulation | 1 | 2020 | 2601 | 0.330 |
Why?
| | Anti-Infective Agents | 1 | 2013 | 232 | 0.320 |
Why?
| | Cardiac Catheterization | 6 | 2021 | 559 | 0.310 |
Why?
| | Polymers | 1 | 2014 | 485 | 0.310 |
Why?
| | Mice, Inbred C57BL | 4 | 2025 | 5992 | 0.290 |
Why?
| | Biomarkers | 2 | 2023 | 4302 | 0.250 |
Why?
| | Image Interpretation, Computer-Assisted | 3 | 2018 | 288 | 0.240 |
Why?
| | Animals | 11 | 2025 | 38100 | 0.230 |
Why?
| | Humans | 36 | 2024 | 145750 | 0.220 |
Why?
| | Vascular Stiffness | 4 | 2017 | 487 | 0.220 |
Why?
| | Mice | 6 | 2025 | 18357 | 0.200 |
Why?
| | Male | 21 | 2025 | 72992 | 0.200 |
Why?
| | Hypertrophy, Right Ventricular | 2 | 2023 | 149 | 0.200 |
Why?
| | Forecasting | 2 | 2024 | 390 | 0.200 |
Why?
| | Child | 12 | 2024 | 22738 | 0.190 |
Why?
| | Blood Pressure | 2 | 2021 | 1782 | 0.180 |
Why?
| | Fontan Procedure | 1 | 2024 | 192 | 0.180 |
Why?
| | Perfusion Imaging | 2 | 2019 | 66 | 0.170 |
Why?
| | Bone Morphogenetic Protein Receptors, Type II | 1 | 2021 | 51 | 0.170 |
Why?
| | Lung | 2 | 2022 | 4116 | 0.170 |
Why?
| | Female | 18 | 2025 | 79025 | 0.160 |
Why?
| | Bone Morphogenetic Proteins | 1 | 2021 | 143 | 0.160 |
Why?
| | Hypoxia | 3 | 2023 | 1199 | 0.160 |
Why?
| | Proof of Concept Study | 1 | 2020 | 89 | 0.160 |
Why?
| | Tacrolimus | 1 | 2021 | 196 | 0.160 |
Why?
| | Predictive Value of Tests | 3 | 2021 | 2123 | 0.160 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 2 | 2018 | 920 | 0.160 |
Why?
| | Transcriptome | 2 | 2024 | 1043 | 0.150 |
Why?
| | Respiratory Mechanics | 1 | 2020 | 74 | 0.150 |
Why?
| | Cardiac Output | 2 | 2017 | 179 | 0.150 |
Why?
| | Gene Expression Profiling | 2 | 2024 | 1777 | 0.150 |
Why?
| | Ventricular Function, Left | 2 | 2020 | 544 | 0.150 |
Why?
| | Image Processing, Computer-Assisted | 2 | 2021 | 782 | 0.150 |
Why?
| | Sensitivity and Specificity | 3 | 2022 | 2000 | 0.140 |
Why?
| | Thermodilution | 1 | 2017 | 16 | 0.130 |
Why?
| | Pulmonary Wedge Pressure | 1 | 2017 | 67 | 0.130 |
Why?
| | Echocardiography, Doppler | 1 | 2018 | 115 | 0.130 |
Why?
| | Betacoronavirus | 1 | 2020 | 289 | 0.130 |
Why?
| | Cognitive Dysfunction | 1 | 2023 | 468 | 0.130 |
Why?
| | Alzheimer Disease | 1 | 2023 | 630 | 0.120 |
Why?
| | Magnetic Resonance Imaging | 3 | 2024 | 3915 | 0.120 |
Why?
| | Nitric Oxide | 1 | 2021 | 892 | 0.120 |
Why?
| | Aortic Diseases | 1 | 2017 | 125 | 0.120 |
Why?
| | Lung Diseases | 1 | 2023 | 782 | 0.120 |
Why?
| | Echinococcosis, Pulmonary | 1 | 2015 | 7 | 0.120 |
Why?
| | Prospective Studies | 5 | 2021 | 8075 | 0.110 |
Why?
| | Aorta, Thoracic | 1 | 2017 | 286 | 0.110 |
Why?
| | Ventricular Dysfunction, Left | 1 | 2018 | 394 | 0.110 |
Why?
| | Adhesiveness | 1 | 2014 | 18 | 0.110 |
Why?
| | Rats | 1 | 2023 | 5585 | 0.110 |
Why?
| | Oxygen Consumption | 1 | 2017 | 719 | 0.100 |
Why?
| | Aorta | 1 | 2017 | 440 | 0.100 |
Why?
| | Contrast Media | 1 | 2017 | 497 | 0.100 |
Why?
| | Reproducibility of Results | 3 | 2017 | 3416 | 0.100 |
Why?
| | Administration, Intravaginal | 1 | 2013 | 19 | 0.100 |
Why?
| | Compliance | 1 | 2013 | 50 | 0.100 |
Why?
| | Blood Circulation | 1 | 2013 | 44 | 0.100 |
Why?
| | Bioengineering | 1 | 2013 | 20 | 0.090 |
Why?
| | Aneurysm, Ruptured | 1 | 2013 | 38 | 0.090 |
Why?
| | Solutions | 1 | 2013 | 159 | 0.090 |
Why?
| | Severity of Illness Index | 5 | 2019 | 2933 | 0.090 |
Why?
| | Aneurysm | 1 | 2013 | 37 | 0.090 |
Why?
| | Familial Primary Pulmonary Hypertension | 2 | 2024 | 196 | 0.090 |
Why?
| | Child, Preschool | 5 | 2021 | 11866 | 0.090 |
Why?
| | Epithelium | 1 | 2013 | 311 | 0.090 |
Why?
| | Surface Properties | 1 | 2013 | 386 | 0.090 |
Why?
| | Pressure | 1 | 2013 | 226 | 0.090 |
Why?
| | Fibroblasts | 3 | 2023 | 1027 | 0.090 |
Why?
| | Adolescent | 7 | 2021 | 22569 | 0.090 |
Why?
| | Swine | 1 | 2014 | 826 | 0.090 |
Why?
| | Pandemics | 1 | 2020 | 1711 | 0.090 |
Why?
| | Aortic Aneurysm, Abdominal | 1 | 2013 | 167 | 0.090 |
Why?
| | Retrospective Studies | 5 | 2021 | 17322 | 0.080 |
Why?
| | Vagina | 1 | 2013 | 203 | 0.080 |
Why?
| | Time Factors | 5 | 2021 | 7133 | 0.080 |
Why?
| | Case-Control Studies | 4 | 2019 | 3634 | 0.080 |
Why?
| | Heart Failure | 1 | 2023 | 2326 | 0.070 |
Why?
| | Middle Aged | 7 | 2024 | 36297 | 0.070 |
Why?
| | Skin | 1 | 2014 | 754 | 0.070 |
Why?
| | Precision Medicine | 1 | 2013 | 461 | 0.070 |
Why?
| | Signal Transduction | 1 | 2021 | 5223 | 0.070 |
Why?
| | Disease Progression | 1 | 2015 | 2865 | 0.060 |
Why?
| | Elasticity | 2 | 2019 | 189 | 0.060 |
Why?
| | Endothelial Cells | 2 | 2023 | 877 | 0.060 |
Why?
| | Follow-Up Studies | 3 | 2021 | 5428 | 0.060 |
Why?
| | Myocardium | 2 | 2021 | 935 | 0.060 |
Why?
| | Proteomics | 2 | 2023 | 1188 | 0.060 |
Why?
| | Age Factors | 3 | 2019 | 3346 | 0.060 |
Why?
| | Infant | 4 | 2021 | 10089 | 0.050 |
Why?
| | Cohort Studies | 1 | 2015 | 6032 | 0.050 |
Why?
| | Vena Cava, Inferior | 1 | 2024 | 83 | 0.050 |
Why?
| | Amyloidogenic Proteins | 1 | 2023 | 16 | 0.050 |
Why?
| | tau Proteins | 1 | 2023 | 105 | 0.050 |
Why?
| | Mechanotransduction, Cellular | 1 | 2023 | 121 | 0.040 |
Why?
| | Intercellular Signaling Peptides and Proteins | 1 | 2023 | 376 | 0.040 |
Why?
| | Endothelium-Dependent Relaxing Factors | 1 | 2021 | 17 | 0.040 |
Why?
| | Mice, Mutant Strains | 1 | 2021 | 302 | 0.040 |
Why?
| | Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2023 | 298 | 0.040 |
Why?
| | Amyloid beta-Peptides | 1 | 2023 | 245 | 0.040 |
Why?
| | Cluster Analysis | 1 | 2022 | 501 | 0.040 |
Why?
| | Cattle | 1 | 2023 | 946 | 0.040 |
Why?
| | Young Adult | 4 | 2019 | 14250 | 0.040 |
Why?
| | Sequence Analysis, RNA | 1 | 2022 | 442 | 0.040 |
Why?
| | Administration, Inhalation | 1 | 2021 | 571 | 0.040 |
Why?
| | Dimensional Measurement Accuracy | 1 | 2019 | 12 | 0.040 |
Why?
| | Peptide Fragments | 1 | 2023 | 696 | 0.040 |
Why?
| | Suture Techniques | 1 | 2020 | 137 | 0.040 |
Why?
| | Myocytes, Cardiac | 1 | 2024 | 546 | 0.040 |
Why?
| | Aged | 4 | 2022 | 26212 | 0.040 |
Why?
| | Numerical Analysis, Computer-Assisted | 1 | 2018 | 19 | 0.030 |
Why?
| | Exercise Tolerance | 1 | 2020 | 283 | 0.030 |
Why?
| | Heart Failure, Diastolic | 1 | 2018 | 23 | 0.030 |
Why?
| | Comparative Effectiveness Research | 1 | 2019 | 169 | 0.030 |
Why?
| | Finite Element Analysis | 1 | 2018 | 67 | 0.030 |
Why?
| | Rheology | 1 | 2018 | 94 | 0.030 |
Why?
| | Viscosity | 1 | 2018 | 92 | 0.030 |
Why?
| | Genomics | 1 | 2023 | 831 | 0.030 |
Why?
| | Prognosis | 2 | 2017 | 4329 | 0.030 |
Why?
| | Aftercare | 1 | 2019 | 222 | 0.030 |
Why?
| | Phantoms, Imaging | 1 | 2018 | 159 | 0.030 |
Why?
| | Statistics, Nonparametric | 1 | 2018 | 428 | 0.030 |
Why?
| | Dilatation, Pathologic | 1 | 2017 | 61 | 0.030 |
Why?
| | Shear Strength | 1 | 2017 | 73 | 0.030 |
Why?
| | Printing, Three-Dimensional | 1 | 2018 | 101 | 0.030 |
Why?
| | Heart Defects, Congenital | 1 | 2024 | 910 | 0.030 |
Why?
| | Recovery of Function | 1 | 2020 | 716 | 0.030 |
Why?
| | Pulse Wave Analysis | 1 | 2017 | 267 | 0.030 |
Why?
| | Linear Models | 1 | 2018 | 849 | 0.030 |
Why?
| | Cells, Cultured | 1 | 2023 | 4151 | 0.030 |
Why?
| | Adult | 3 | 2024 | 40867 | 0.030 |
Why?
| | Clinical Decision-Making | 1 | 2019 | 364 | 0.030 |
Why?
| | Reference Values | 1 | 2017 | 798 | 0.030 |
Why?
| | Cytokines | 1 | 2023 | 2069 | 0.030 |
Why?
| | Analysis of Variance | 1 | 2018 | 1300 | 0.030 |
Why?
| | Cognition | 1 | 2023 | 1271 | 0.030 |
Why?
| | Phenotype | 1 | 2023 | 3170 | 0.030 |
Why?
| | Area Under Curve | 1 | 2015 | 332 | 0.030 |
Why?
| | Macrophages | 1 | 2022 | 1507 | 0.030 |
Why?
| | Myocardial Contraction | 1 | 2015 | 293 | 0.030 |
Why?
| | ROC Curve | 1 | 2015 | 618 | 0.020 |
Why?
| | Biomechanical Phenomena | 1 | 2017 | 860 | 0.020 |
Why?
| | Societies, Scientific | 1 | 2013 | 50 | 0.020 |
Why?
| | Angiography | 1 | 2013 | 208 | 0.020 |
Why?
| | Survival Rate | 1 | 2017 | 2094 | 0.020 |
Why?
| | Risk Factors | 2 | 2017 | 10916 | 0.020 |
Why?
| | Congresses as Topic | 1 | 2013 | 224 | 0.020 |
Why?
| | Feasibility Studies | 1 | 2015 | 1115 | 0.020 |
Why?
| | Inflammation | 1 | 2022 | 2883 | 0.020 |
Why?
| | Kinetics | 1 | 2013 | 1568 | 0.020 |
Why?
| | Tomography, X-Ray Computed | 1 | 2019 | 2770 | 0.020 |
Why?
| | Risk Assessment | 1 | 2013 | 3752 | 0.010 |
Why?
|
|
Kheyfets's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|